No 37, Guoxue Road
Wuhou District
Chengdu, Sichuan Province 610041
China
Sichuan University - Department of Thoracic Surgery
esophageal cancer, neoadjuvant therapy, adjuvant therapy, survival, meta-analysis
neoadjuvant immunotherapy, camrelizumab, esophageal squamous cell carcinoma, clinical efficacy, immune response
esophageal cancer, global burden of disease, risk factor, modifiable behaviroal risk, lifestyle-based cancer prevention